(Q30650570)

English

Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 June 2017

Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature (English)

1 reference

Europe PubMed Central

25 June 2017

object named as

Paolo Fava

6

0 references

object named as

Paola Savoia

4

1 reference

ORCID Public Data File 2021

author name string

Pietro Quaglino

1

1 reference

Europe PubMed Central

25 June 2017

Robert Knobler

2

1 reference

Europe PubMed Central

25 June 2017

Maria T Fierro

3

1 reference

Europe PubMed Central

25 June 2017

Elena Marra

5

1 reference

Europe PubMed Central

25 June 2017

Maria G Bernengo

7

1 reference

Europe PubMed Central

25 June 2017

publication date

20 June 2013

1 reference

Europe PubMed Central

25 June 2017

International Journal of Dermatology

1 reference

Europe PubMed Central

25 June 2017

52

1 reference

Europe PubMed Central

25 June 2017

11

1 reference

Europe PubMed Central

25 June 2017

1308-1318

1 reference

Europe PubMed Central

25 June 2017

Cutaneous T-Cell Lymphomas: The Sézary Syndrome, Mycosis Fungoides, and Related Disorders

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

WHO-EORTC classification for cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Mycosis fungoides and Sézary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Defining early mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis: past, present, and future

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis: how, when, and why.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Update on extracorporeal photopheresis in heart and lung transplantation

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis: a focus on apoptosis and cytokines

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Tolerogenic dendritic cells and regulatory T cells: a two-way relationship

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

An integrated view of suppressor T cell subsets in immunoregulation

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

The molecular and clinical rationale of extracorporeal photochemotherapy in autoimmune diseases, malignancies and transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Improved generation of anti-tumor immunity by antigen dose limitation

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Photopheresis in the treatment of cutaneous T-cell lymphoma: current status

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

The treatment of cutaneous T-cell lymphoma with photopheresis

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photochemotherapy--the Columbia Presbyterian experience

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Circulating CD4+CD7− Lymphocyte Burden and Rapidity of Response

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Multicenter photopheresis intervention trial in early-stage mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of

1 reference

https://api.crossref.org/works/10.1111%2FIJD.12121

21 January 2018

Identifiers

10.1111/IJD.12121

1 reference

Europe PubMed Central

25 June 2017

1 reference

Europe PubMed Central

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30650570&oldid=1577097822"